Advancing lifechanging medicine: gRNA in the spotlight
The promise of gene-editing therapies has passed the realm of scientific possibility to clinical reality. While DNA-altering treatments are considered…
The promise of gene-editing therapies has passed the realm of scientific possibility to clinical reality. While DNA-altering treatments are considered…
According to GlobalData, the biopharmaceutical industry commenced 398 clinical trials for CAR-T therapies in 2024 – an increase of greater…
Oral liquid dosage forms are essential in the pharmaceutical industry, catering to the needs of patients who have difficulty swallowing…
This development is driven by the rise of personalized medicine, orphan drugs, and advanced biologics, each requiring highly flexible and…
As the world of small molecule pharmaceuticals advances, the combination of high pharmacological activity with greater selectivity is delivering therapeutic…
The pharma sector contributes 5% of global GHG emissions1, a fact that has helped drive the top 46% of pharmaceutical…
Philadelphia, PA – PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative…
Once a drug receives regulatory approval, the clock starts ticking to get high-quality products packed, shipped, and available on the…
Between the start of 2022 and the end of 2024, GlobalData’s Drugs database recorded 160 US approvals for currently marketed…
In the high-stakes world of clinical trials, timing is everything, but that doesn’t mean faster is always better. In the…